Navigation Links
COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1)
Date:11/17/2010

RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2010 /PRNewswire/ -- Patients with Chronic Obstructive Pulmonary Disease, or COPD, revealed that they perceive their disease as both a burden they must deal with and as a loss they have experienced,(1) according to recent in-home research conducted by GlaxoSmithKline.  Patients participating in the research characterized their sense of loss as a combination of factors including loss of energy, loss of control, loss of independence and loss of their old self.  They also suggested that COPD prevents them from living life to its fullest(1).  As the disease progresses, research participants report they've become increasingly limited in what they can do and more reliant on the internet as a source of important information on how to help manage their illness and as a means to interact with other people who can share in their experiences(1).

Patients with COPD can learn more on how to manage their disease by visiting www.COPD.com.  For the 12 million individuals diagnosed with COPD in the United States(2), www.COPD.com offers an easily accessible online destination to help inform them on their disease and its different stages and offers them things to consider that may help them live with COPD.  For caregivers, www.COPD.com offers information on how to care for a loved one with COPD.

About COPDAs the fourth leading cause of death in the United States(3), there are about 120,000 deaths attributed to COPD annually, more than breast cancer and diabetes combined(4). Every four minutes, someone dies from COPD in the United States(5). In addition to the 12 million individuals diagnosed with COPD, there are an additional 12 million people estimated with undiagnosed COPD(6).

COPD is a progressive, life-threatening lung disease that includes chronic bronchitis and emphysema. It is characterized by airflow obstruction, which leads to the hallmark symptoms of COPD - chronic cough, chest tightness, shortness of breath, increased effort to breathe and increased mucus production. Over time, patients with COPD suffer from shortness of breath so severe that it interferes with the most basic daily activities including sleeping, talking, and even dressing.

About World COPD DayWorld COPD Day is an annual event organized by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to improve awareness and care of chronic obstructive pulmonary disease (COPD) around the world. World COPD Day 2010 will take place on November 17 around the theme "2010 - The Year of the Lung: Measure your lung health - Ask your doctor about a simple breathing test called spirometry."About the ResearchIn-home interviews were conducted with 16 COPD patients in Phoenix, AZ, and New York, NY.  The goals of the interviews were to uncover first-hand insights into how the disease impacts patient lives; understand who the COPD sufferer is, including lifestyle elements and life goals that may be compromised because of COPD; and to identify perceptions about COPD and participants' core emotions in living with the disease.

Respondents had a range of disease severity and included a representative mix of respondents in terms of age, income level, race, and education.

All research participants had been diagnosed with COPD, including chronic bronchitis and/or emphysema. The in-home setting also enabled engagement with patient family members to see how living with the condition affects the caregiver.  

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information go to us.gsk.com, follow us on twitter.com/GSKUS or visit our blog (www.morethanmedicine.us.gsk.com/blog/). Inquiries:US Media Inquiries:

Patty Johnson

(919) 483 2839Cautionary statement regarding forward-looking statementsUnder the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2009.References:

  1. GlaxoSmithKline In-Home COPD Research Findings: Data on File 2009
  2. National Heart Lung and Blood Institutes.  Morbidity and Mortality: 2009 Chartbook on Cardiovascular, Lung and Blood Diseases.
  3. National Heart, Lung and Blood Institute.  COPD Key Points.  http://www.nhlbi.nih.gov/health/dci/Diseases/Copd/Copd_KeyPoints.html; Accessed 7/2010
  4. National Center for Health Statistics.  Deaths:  Final data for 2006. www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_14.pdf.  Updated April 17, 2009.  
  5. COPD Foundation: Facts about COPD; 2008.
  6. National Heart Lung and Blood Institutes.  Morbidity and Mortality: 2009 Chartbook on Cardiovascular, Lung and Blood Diseases.


'/>"/>

SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
2. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
3. Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery
4. Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery
5. First-Line Use of Abilify Has More Than Doubled Over the Past Year for the Treatment of Newly-Diagnosed Patients in Bipolar Disorder
6. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices
7. NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
8. New Study: Overuse of Combination Drug Therapy in Patients with Mild Asthma Leads to Increased Costs
9. Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease
10. Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
11. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):